BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32639940)

  • 1. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury.
    Kow CS; Hasan SS
    J Am Soc Nephrol; 2020 Aug; 31(8):1917-1918. PubMed ID: 32639940
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
    Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Authors' Reply.
    Batlle D; Soler MJ; Welling PA; Swaminathan S;
    J Am Soc Nephrol; 2020 Aug; 31(8):1918-1919. PubMed ID: 32636207
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there enough evidence to discontinue the renin-angiotensin system inhibitors in patients with COVID-19?
    Bobkova I; Kamyshova E; Rudenko T; Stavrovskaya E; Moiseev S
    Med Hypotheses; 2020 Oct; 143():109888. PubMed ID: 32480248
    [No Abstract]   [Full Text] [Related]  

  • 5. Renin-angiotensin-aldosterone system inhibitors to treat COVID-19?
    Henry RA
    CMAJ; 2020 Jun; 192(26):E728. PubMed ID: 32601254
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
    Bloch MJ
    J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What Kind of Evidence Is Needed to Dictate Practice Regarding Inhibitors of the Renin-Angiotensin System in COVID-19?
    Elijovich F; Laffer CL
    Hypertension; 2020 Sep; 76(3):665-669. PubMed ID: 32783759
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 10. Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
    Silhol F; Sarlon G; Deharo JC; Vaïsse B
    Hypertens Res; 2020 Aug; 43(8):854-856. PubMed ID: 32439915
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
    Çiftçiler R; Haznedaroğlu İC
    Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
    [No Abstract]   [Full Text] [Related]  

  • 12. The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
    Sever P; Johnston SL
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926911. PubMed ID: 32403977
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection.
    Kessler T; Schunkert H
    Herz; 2020 Jun; 45(4):323-324. PubMed ID: 32274522
    [No Abstract]   [Full Text] [Related]  

  • 15. Obstructive sleep apnea, renin-angiotensin system, and COVID-19: possible interactions.
    Ekiz T; İnönü Köseoğlu H; Pazarlı AC
    J Clin Sleep Med; 2020 Aug; 16(8):1403-1404. PubMed ID: 32807298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Quinn KL; Fralick M; Zipursky JS; Stall NM
    CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019.
    Tedeschi S; Giannella M; Bartoletti M; Trapani F; Tadolini M; Borghi C; Viale P
    Clin Infect Dis; 2020 Jul; 71(15):899-901. PubMed ID: 32339215
    [No Abstract]   [Full Text] [Related]  

  • 18. Gustatory dysfunctions in COVID-19 patients: possible involvement of taste renin-angiotensin system (RAS).
    Bigiani A
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2395. PubMed ID: 32435852
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
    Henry BM; Benoit S; Lippi G; Benoit J
    Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.